Table 3.
MΦ (IL-12 pg/ml) | MΦ + ΝΚ (IL-12 pg/ml) | MΦ + LPS (IL-12 pg/ml) | MΦ + NK + LPS (IL-12 pg/ml) | |
---|---|---|---|---|
WT | 7·7 ± 1·0 | 7·7 ± 1·0 | 9·2 ± 0·9 | 6·0 ± 1·0 |
CD40–/–* | 18·7 ± 3·0 | 15·2 ± 1·2 | 19·2 ± 1·9 | 15·0 ± 2·3 |
CD154–/– | 13·0 ± 2·1 | 10·6 ± 0·4 | 11·8 ± 1·3 | 10·0 ± 2·6 |
IFNγ–/– | 8·2 ± 2·5 | 10·2 ± 2·5 | 8·8 ± 2·2 | 3·0 ± 0·9¶ |
MΦ, peritoneal macrophages; NK, splenic NK cells; LPS, lipopolysaccharide; WT, wild type C57BL/6 mice; n = 6 per group, averaged repeated experiments
P < 0·05 WT versus CD40–/–.
P < 0·05 MΦ + NK + LPS (IFN-γ–/–) versus MΦ or MΦ + NK or MΦ + LPS (IFN-γ–/–).